Skip to content
Clinical Trial Events
BIO-Europe 2026

Fireside chat Clinical Strategy track

Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic

Tue, Nov 10, 2026 · 2:30–3:00 PM CET Clinical Strategy Stage, Koelnmesse

About this session

Australia offers a compelling opportunity for clinical trials, with favorable regulatory framework, strong networks, excellent engagement with clinicians/researchers, and access to established and proven pathways of obtaining high-quality clinical data recognised by European and US regulators, and other global institutions. This speaking session will highlight how Australia’s clinical trials are a cornerstone for innovation and attractive environment for companies from around the world to develop their intellectual property.

Speakers

  • Lisa Nelson

    CEO · Scientia Clinical Research Ltd

    Moderator

  • Matthew Bugg

    COO · MaH Pharma Pty Ltd

    Speaker

  • Morgan Evans

    CSO · Agilex Biolabs

    Speaker

  • Teresa Karnatz

    Senior Director of Business Development (Europe & UK) · Biocina Pty Ltd

    Speaker

  • Meredith Manuel

    Head of Business Development · Avion CRO & Imaging Specialists

    Speaker